Literature DB >> 32304409

Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer.

Mingwei Chen1, Yanliang Zheng1, Jingfang Xie1, Enming Zhen2, Xiaoqing Zhou1.   

Abstract

A growing number of studies have revealed the critical roles of long noncoding RNAs (lncRNAs) in the tumorigenesis and cancer progression. Recently, next-generation sequencing technologies combined with bioinformatic have demonstrated that a great number of dysregulated lncRNAs are associated with diverse cancers. However, lots of lncRNAs' function and their underlying molecular mechanisms in oral carcinoma (OC) cancer remain unclear. In this study, we performed integrative lncRNA profiling analysis using the TCGA RNA sequencing data and gene microarray data from Gene Expression Omnibus to identify more OC associated lncRNAs. A total of 619 differentially expressed lncRNAs were identified between the five data sets, and only the double homeobox A pseudogene 8 (DUXAP8) was screened among the up-regulated lncRNAs in all the five groups. Meanwhile, univariate Cox regression analyses disclosed that some lncRNAs are associated with the outcome of OC patients, such as DUXAP8, LINC00152, MIR4435-2HG and LINC00582. Furthermore, we uncovered that silenced DUXAP8 expression exerted suppressive impact on the proliferation of OC cells through interacting with histone-lysine N-methyltransferase enzyme Enhancer of zeste homolog 2 (EZH2) and repressing KLF2 expression. In a word, we identified a lot of unreported OC associated lncRNAs, which may provide a useful resource of lncRNAs for other studies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32304409     DOI: 10.1097/CAD.0000000000000936

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  5 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.

Authors:  Chen Gao; Ning Kong; Fan Zhang; Tianyu Tang; Jiaying Li; Honglei Ding; Zhichao Sun; Linyu Wu; Maosheng Xu
Journal:  BMC Med Genomics       Date:  2022-01-29       Impact factor: 3.063

3.  LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.

Authors:  Yongfeng Wang; Xianglai Jiang; Dongzhi Zhang; Yuanbin Zhao; Xiaoyong Han; Lihui Zhu; Jingyao Ren; Yubin Liu; Jiarong You; Haolan Wang; Hui Cai
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

Review 4.  The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?

Authors:  Maciej Stasiak; Tomasz Kolenda; Joanna Kozłowska-Masłoń; Joanna Sobocińska; Paulina Poter; Kacper Guglas; Anna Paszkowska; Renata Bliźniak; Anna Teresiak; Urszula Kazimierczak; Katarzyna Lamperska
Journal:  Life (Basel)       Date:  2021-12-07

5.  LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.

Authors:  Xianguang Yang; Susheng Miao; Xionghui Mao; Cheng Xiu; Ji Sun; Rong Pei; Shenshan Jia
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.